BACKGROUND AND PURPOSE: The best approach between general anesthesia and conscious sedation to perform mechanical thrombectomy remains unknown. The goal of our study was to evaluate the feasibility, safety, and efficacy of mechanical thrombectomy under conscious sedation in patients with acute ischemic stroke, using the Solitaire FR device, in a prospective, single-center, single-arm study. MATERIALS AND METHODS: The study included consecutive patients with acute ischemic stroke due to a large artery occlusion within 6 hours of symptom onset for the anterior circulation, and within 24 hours for the posterior circulation. After intravenous thrombolysis (when no contraindications), thrombectomy was performed with the Solitaire device in patients under conscious sedation. Primary efficacy and safety end points were good functional outcome (mRS ≤2) at 3 months and mortality at 3 months. Secondary end points were recanalization (TICI ≥2) and failure rate. RESULTS: From May 2010 to July 2011, 36 patients were treated. Median baseline NIHSS score was 17.5. The occlusion site was MCA in 21 patients (58.4%), ICA-MCA tandem occlusion in 9 patients (25.0%), terminal ICA in 2 patients (5.5%), and basilar artery in 4 patients (11.1%). Twenty-three patients (63.9%) received intravenous thrombolysis. Superselective catheterization of the occluded vessel was not feasible in 5/36 cases (13.9%). Successful revascularization was achieved in 28/36 patients (77.8%). After 3 months, 22 patients (61.1%) showed good functional outcome (mRS ≤2) and the median NIHSS score was 8.5. Overall mortality rate at 3 months was 22.2% (8/36). CONCLUSIONS: In acute ischemic stroke, mechanical thrombectomy while under conscious sedation is feasible in a large percentage of cases (86.1%) and is associated with a short procedure delay and a high percentage of good functional outcomes at 3 months (61.1%).
BACKGROUND AND PURPOSE: The best approach between general anesthesia and conscious sedation to perform mechanical thrombectomy remains unknown. The goal of our study was to evaluate the feasibility, safety, and efficacy of mechanical thrombectomy under conscious sedation in patients with acute ischemic stroke, using the Solitaire FR device, in a prospective, single-center, single-arm study. MATERIALS AND METHODS: The study included consecutive patients with acute ischemic stroke due to a large artery occlusion within 6 hours of symptom onset for the anterior circulation, and within 24 hours for the posterior circulation. After intravenous thrombolysis (when no contraindications), thrombectomy was performed with the Solitaire device in patients under conscious sedation. Primary efficacy and safety end points were good functional outcome (mRS ≤2) at 3 months and mortality at 3 months. Secondary end points were recanalization (TICI ≥2) and failure rate. RESULTS: From May 2010 to July 2011, 36 patients were treated. Median baseline NIHSS score was 17.5. The occlusion site was MCA in 21 patients (58.4%), ICA-MCA tandem occlusion in 9 patients (25.0%), terminal ICA in 2 patients (5.5%), and basilar artery in 4 patients (11.1%). Twenty-three patients (63.9%) received intravenous thrombolysis. Superselective catheterization of the occluded vessel was not feasible in 5/36 cases (13.9%). Successful revascularization was achieved in 28/36 patients (77.8%). After 3 months, 22 patients (61.1%) showed good functional outcome (mRS ≤2) and the median NIHSS score was 8.5. Overall mortality rate at 3 months was 22.2% (8/36). CONCLUSIONS: In acute ischemic stroke, mechanical thrombectomy while under conscious sedation is feasible in a large percentage of cases (86.1%) and is associated with a short procedure delay and a high percentage of good functional outcomes at 3 months (61.1%).
Authors: Mouhammad A Jumaa; Fan Zhang; Gerardo Ruiz-Ares; Theresa Gelzinis; Amer M Malik; Aitziber Aleu; Jennifer I Oakley; Brian Jankowitz; Ridwan Lin; Vivek Reddy; Syed F Zaidi; Maxim D Hammer; Lawrence R Wechsler; Michael Horowitz; Tudor G Jovin Journal: Stroke Date: 2010-04-29 Impact factor: 7.914
Authors: J H Pexman; P A Barber; M D Hill; R J Sevick; A M Demchuk; M E Hudon; W Y Hu; A M Buchan Journal: AJNR Am J Neuroradiol Date: 2001-09 Impact factor: 3.825
Authors: Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks Journal: Stroke Date: 2003-07-17 Impact factor: 7.914
Authors: Erich Bluhmki; Angel Chamorro; Antoni Dávalos; Thomas Machnig; Christophe Sauce; Nils Wahlgren; Joanna Wardlaw; Werner Hacke Journal: Lancet Neurol Date: 2009-10-21 Impact factor: 44.182
Authors: Wade S Smith; Gene Sung; Jeffrey Saver; Ronald Budzik; Gary Duckwiler; David S Liebeskind; Helmi L Lutsep; Marilyn M Rymer; Randall T Higashida; Sidney Starkman; Y Pierre Gobin; Donald Frei; Thomas Grobelny; Frank Hellinger; Dan Huddle; Chelsea Kidwell; Walter Koroshetz; Michael Marks; Gary Nesbit; Isaac E Silverman Journal: Stroke Date: 2008-02-28 Impact factor: 7.914
Authors: David L McDonagh; Daiwai M Olson; Junaid S Kalia; Rishi Gupta; Alex Abou-Chebl; Osama O Zaidat Journal: Front Neurol Date: 2010-11-11 Impact factor: 4.003
Authors: Paolo Machi; Vincent Costalat; Kyriakos Lobotesis; Igor Lima Maldonado; Jean Francois Vendrell; Carlos Riquelme; Alain Bonafé Journal: J Neurointerv Surg Date: 2011-04-07 Impact factor: 5.836
Authors: W Brinjikji; M H Murad; A A Rabinstein; H J Cloft; G Lanzino; D F Kallmes Journal: AJNR Am J Neuroradiol Date: 2014-11-13 Impact factor: 3.825
Authors: L Pierot; M Söderman; M Bendszus; P White; M Muto; F Turjman; S Mangiafico; J Gralla; J Fiehler; I Szikora; C Cognard Journal: Neuroradiology Date: 2013-11 Impact factor: 2.804
Authors: Kajo van der Marel; Ju-Yu Chueh; Olivia W Brooks; Robert M King; Miklos G Marosfoi; Erin T Langan; Sarena L Carniato; Matthew J Gounis; Raul G Nogueira; Ajit S Puri Journal: J Neurointerv Surg Date: 2016-02-01 Impact factor: 5.836